Internal Medicine, Pulmonary Disease · Muncie, IN
NPI
1114995545
Since 2006
Specialty
Internal Medicine, Pulmonary Disease
Code 207RP1001X
Group practices
3
Medicare group memberships
Hospitals
5
Hospital affiliations
2401 W University Ave
Muncie, IN, 47303
Phone (765) 747-3111
Groups this clinician bills Medicare through
Medicare paid, 2024
$153K
2,479 services
Medicare patients, 2024
469
Average age 75
Drug cost, 2024
$1.5M
4,003 prescriptions
Company payments, 2025
$5,771
From 12 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Rajeev Mehta was code 99232 (hospital e&m - subsequent), 670 times for 130 patients. In total Rajeev Mehta billed 2,479 services in 33 codes, and Medicare paid $153K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2021-01-27.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99232 Hospital E&M - Subsequent | Facility | 670 | 130 | $57.04 | $38K |
| 99214 Office E&M - Established | Office | 347 | 211 | $86.81 | $30K |
| 94727 Pulmonary Function Testing | Office | 212 | 210 | $30.74 | $6,517 |
| 94729 Pulmonary Function Testing | Office | 212 | 210 | $37.22 | $7,891 |
| 94010 Pulmonary Function Testing | Office | 194 | 192 | $18.39 | $3,567 |
| 99291 Critical Care E&M | Facility | 168 | 48 | $154.29 | $26K |
| 99213 Office E&M - Established | Office | 157 | 130 | $52.65 | $8,266 |
| 99231 Hospital E&M - Subsequent | Facility | 141 | 67 | $36.22 | $5,107 |
| 99233 Hospital E&M - Subsequent | Facility | 52 | 37 | $87.15 | $4,532 |
| 99223 Hospital E&M - Initial | Facility | 44 | 42 | $125.35 | $5,515 |
| 99292 Critical Care E&M | Facility | 34 | 23 | $78.13 | $2,656 |
| 99222 Hospital E&M - Initial | Facility | 31 | 27 | $92.32 | $2,862 |
| 94664 E&M - Miscellaneous | Office | 19 | 19 | $12.72 | $242 |
| 94060 Pulmonary Function Testing | Office | 19 | 19 | $25.26 | $480 |
| 90662 Vaccine Product | Office | 17 | 17 | $80.07 | $1,361 |
By year: 2022 $184K for 3,162 services; 2023 $183K for 3,074 services; 2024 $153K for 2,479 services.
Medicare prescription drug claims, 2024
In 2024, the drug Rajeev Mehta prescribed most often to Medicare patients was Montelukast Sodium, with 771 prescriptions and refills. In total Rajeev Mehta wrote 4,003 Medicare prescriptions that cost $1.5M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Montelukast Sodium Generic | 771 | 1,850 | 201 | $8,855 |
| Trelegy Ellipta Fluticasone/Umeclidin/Vilanter | 600 | 906 | 123 | $562K |
| Albuterol Sulfate Hfa Albuterol Sulfate | 343 | 429 | 125 | $9,539 |
| Theophylline Er Theophylline Anhydrous | 269 | 564 | 64 | $25K |
| Prednisone Generic | 269 | 438 | 87 | $1,337 |
| Spiriva Respimat Tiotropium Bromide | 156 | 260 | 35 | $135K |
| Symbicort Budesonide/Formoterol Fumarate | 136 | 201 | 28 | $45K |
| Anoro Ellipta Umeclidinium Brm/Vilanterol Tr | 125 | 207 | 31 | $96K |
| Pantoprazole Sodium Generic | 109 | 225 | 29 | $1,988 |
| Stiolto Respimat Tiotropium Br/Olodaterol Hcl | 103 | 205 | 30 | $96K |
| Fluticasone-Salmeterol Fluticasone Propion/Salmeterol | 102 | 168 | 25 | $19K |
| Azithromycin Generic | 96 | 129 | 14 | $1,151 |
| Breo Ellipta Fluticasone/Vilanterol | 94 | 144 | 24 | $57K |
| Fluticasone Propionate Generic | 66 | 123 | 24 | $2,982 |
| Spiriva Handihaler Tiotropium Bromide | 62 | 101 | 16 | $50K |
Brand drugs: 1,862 claims; generic drugs: 2,141 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Rajeev Mehta $5,771 ($5,771 in general payments such as food, travel and fees) from 12 companies. The largest payer was Genzyme Corporation with $4,735.
| Company | Payments | Amount |
|---|---|---|
| Genzyme Corporation SNY | 11 | $4,735 |
| AstraZeneca Pharmaceuticals LP AZN | 15 | $333 |
| Regeneron Healthcare Solutions, Inc. REGN | 6 | $158 |
| Viatris Specialty LLC | 5 | $86.25 |
| Amgen Inc. AMGN | 4 | $79.63 |
| Takeda Pharmaceuticals U.S.A., Inc. TAK | 4 | $76.98 |
| GlaxoSmithKline, LLC. GSK | 4 | $76.77 |
| Verona Pharma, Inc. VRNA | 4 | $72.04 |
| Alexion Pharmaceuticals, Inc. AZN | 2 | $62.7 |
| Insmed, Inc. INSM | 2 | $36.96 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.